| Literature DB >> 30293784 |
Hong Wang1, Amina Boussouar1, Laetitia Mazelin1, Servane Tauszig-Delamasure1, Yan Sun1, David Goldschneider2, Andrea Paradisi3, Patrick Mehlen4.
Abstract
c-Kit is a classic proto-oncogene either mutated or upregulated in cancer cells, and this leads to its constitutive kinase activation and, thus, to uncontrolled proliferation. Although the pro-oncogenic role of c-Kit is of no doubt, some observations do not fit well with c-Kit solely as a tumor-promoting moiety. We show here that c-Kit actively triggers cell death in various cancer cell lines unless engaged by its ligand stem cell factor (SCF). This pro-death activity is enhanced when the kinase activation of c-Kit is silenced and is due to c-Kit intracellular cleavage by caspase-like protease at D816. Moreover, in vivo, overexpression of a c-Kit kinase-dead mutant inhibits tumor growth, and this intrinsic c-Kit tumor-suppressive activity is dependent on the D816 cleavage. Thus, c-Kit acts both as a proto-oncogene via its kinase activity and as a tumor suppressor via its dependence receptor activity.Entities:
Keywords: SCF; apoptosis; c-Kit; cancer; caspase; dependence receptors; receptor tyrosine kinase
Mesh:
Substances:
Year: 2018 PMID: 30293784 DOI: 10.1016/j.molcel.2018.08.040
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970